A triple-blind, randomized controlled clinical trial involving 44 female patients diagnosed with RA showed that SSC might decrease the number of tender and swollen joints by decreasing serum levels of IL-1β and MMP-3 (90). The gene discussed is IL1B; the disease is rheumatoid arthritis.